AI Article Synopsis

  • Metastasis is a critical process in cancer that leads to most cancer deaths, requiring cancer cells to exit blood vessels to establish new tumor sites.
  • Current treatments fail to effectively target this extravasation step due to insufficient knowledge of the underlying molecular mechanisms.
  • Recent advancements in imaging techniques and models have enhanced our understanding of cancer extravasation, highlighting key stages and factors involved, which could pave the way for new treatments targeting this process.

Article Abstract

Metastasis is a multistep process that accounts for the majority of cancer-related death. By the end of metastasize dissemination, circulating tumor cells (CTC) need to extravasate the blood vessels at metastatic sites to form new colonization. Although cancer cell extravasation is a crucial step in cancer metastasis, it has not been successfully targeted by current anti-metastasis strategies due to the lack of a thorough understanding of the molecular mechanisms that regulate this process. This review focuses on recent progress in cancer extravasation visualization techniques, including the development of both in vitro and in vivo cancer extravasation models, that shed light on the underlying mechanisms. Specifically, multiple cancer extravasation stages, such as the adhesion to the endothelium and transendothelial migration, are successfully probed using these technologies. Moreover, the roles of different cell adhesive molecules, chemokines, and growth factors, as well as the mechanical factors in these stages are well illustrated. Deeper understandings of cancer extravasation mechanisms offer us new opportunities to escalate the discovery of anti-extravasation drugs and therapies and improve the prognosis of cancer patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897269PMC
http://dx.doi.org/10.1007/s10555-020-09942-2DOI Listing

Publication Analysis

Top Keywords

cancer extravasation
20
cancer
7
extravasation
6
visualizing cancer
4
extravasation mechanistic
4
mechanistic studies
4
studies drug
4
drug development
4
development metastasis
4
metastasis multistep
4

Similar Publications

A 10-year-old neutered male Labrador mix dog presented with a few-day history of stranguria and dysuria. Results of physical examination, laboratory findings, and imaging were consistent with a uroperitoneum and prostatomegaly. Ultrasound showed an enlarged, heterogeneous, and lobular prostate with mineralization, and fluoroscopy showed extravasation of contrast from the prostatic urethra through the prostatic parenchyma into the abdomen.

View Article and Find Full Text PDF

Endoplasmic Reticulum-Targeted Polymer-Manganese Nanocomplexes for Tumor Immunotherapy.

ACS Nano

January 2025

Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, China.

Manganese ions (Mn) are an immune activator that enhances the activation of both cGAS and STING proteins. The STING signaling activation and subsequential immune responses are predominantly associated with endoplasmic reticulum (ER). Therefore, ER targeting of Mn in the subcellular compartments would promote the activation of STING signaling pathways.

View Article and Find Full Text PDF

Background: ACKR2 is an atypical chemokine receptor that plays a significant role in regulating inflammation by binding to inflammatory CC chemokines and facilitating their degradation. Previous findings suggest that the genetic absence of ACKR2 leads to heightened tumor growth in inflammation-driven models. Conversely, mice lacking ACKR2 exhibit protection against lung metastasis in melanoma and breast cancer models.

View Article and Find Full Text PDF

Therapeutic strategy for efficiently targeting cancer cells needs an in-depth understanding of the cellular and molecular interplay in the tumor microenvironment (TME). TME comprises heterogeneous cells clustered together to translate tumor initiation, migration, and proliferation. The TME mainly comprises proliferating tumor cells, stromal cells, blood vessels, lymphatic vessels, cancer-associated fibroblasts (CAFs), extracellular matrix (ECM), and cancer stem cells (CSC).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!